273 results
425
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
6 Nov 09
Business combination disclosure
12:00am
acquisitions we will have a presentation with slides that will help frame our business strategy, highlight the recent pending acquisitions and lay out … .
As we look at our continuing business operations a primary focus of our business strategy is strong financial management. Here at Ligand we
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
2 Apr 02
Other events
12:00am
indicate that as many as 30-85% of select chronic pain patients still are
undertreated.
Ligand's sales force strategy for AVINZA … , product potential, benefits of AVINZA for patients, market
size and growth, and sales strategy. Actual events or results may differ from
Ligand's
8-K
EX-99.2
98wjztsy9y we
5 Nov 09
Ligand Pharmaceuticals Announces Third Quarter Results
12:00am
8-K
EX-99
w9x 7f10yhaogtbd
23 Mar 07
Other Events
12:00am
424B3
g55w9uh5id04ek
23 Mar 07
Prospectus supplement
12:00am
8-K
meis 3ci2go2
9 Feb 15
Ligand Reports Fourth Quarter and Full Year 2014 Financial Results
12:00am
8-K
EX-99.1
xil6r
10 May 07
Ligand Pharmaceuticals Announces First Quarter Results
12:00am
8-K
EX-99.1
ra2zbqjice5gcxl
24 Dec 08
Ligand Completes Pharmacopeia Acquisition
12:00am
8-K
8zo2tg
4 Aug 14
Ligand Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
uoar8pd
20 Feb 08
Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
12:00am
8-K
EX-99.1
isb03f
4 Aug 08
Ligand Pharmaceuticals Appoints Dr. Stephen Sabba to Board of Directors
12:00am